Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 78,056 | 71,278 | 73,165 | 63,096 | 75,881 |
| Operating Income | -78,056 | -71,278 | -73,165 | -63,096 | -75,881 |
| Other Income | 8,731 | 6,318 | 7,141 | 7,840 | 8,681 |
| Pre-tax Income | -69,325 | -64,960 | -66,024 | -55,256 | -67,200 |
| Income Tax | 62 | 61 | 72 | 83 | N/A |
| Net Income Continuous | -69,387 | -65,021 | -66,096 | -55,339 | -67,218 |
| Net Income | $-69,387 | $-65,021 | $-66,096 | $-55,339 | $-67,218 |
| EPS Basic Total Ops | -1.03 | -1.11 | -1.13 | -0.95 | -1.20 |
| EPS Basic Continuous Ops | -1.03 | -1.11 | -1.13 | -0.95 | -1.20 |
| EPS Diluted Total Ops | -1.03 | -1.11 | -1.13 | -0.95 | -1.20 |
| EPS Diluted Continuous Ops | -1.03 | -1.11 | -1.13 | -0.95 | -1.20 |
| EPS Diluted Before Non-Recurring Items | -1.03 | -1.11 | -1.13 | -0.95 | -1.19 |
| EBITDA(a) | $-79,392 | $-72,492 | $-74,526 | $-65,268 | $-78,791 |